Further, AR and EMT regulator β-catenin were localized to the nucleus, suggesting that the crosstalk between TGF-β signaling, AR, and EMT mediate progression of prostate cancer to CRPC [134]. This evidence concerns the gene TGFB1 and prostate cancer.